The Benchmark Company
http://www.benchmarkcap.com/default.aspThe Benchmark Company, a full-service Broker Dealer, provides financial services to institutional and private clients. Its services include private placements, venture capital, M&A services, recapitalizations, divestitures & spin-offs, equity research as well as other financial services. The firm’s equity research division specializes in the media, energy, enterprise software, infrastructure software, and biotechnology & specialty pharmaceutical sectors.
View Older Stories View More Recent Stories
-
MTBC Completes Its Offering of Non-Convertible Preferred Stock with $20.7 Million in Gross Proceeds
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Upsizing and Pricing of $18.0 Million Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
MTBC Announces Commencement of Public Offering of Preferred Stock
-
WiMi Hologram Cloud Inc. Announces Closing of Underwritten Initial Public Offering
-
WIMI Hologram Cloud's IPO on NASDAQ, Heralding the Robust Growth in China's AR + AI market
-
WiMi Hologram Cloud (WIMI) Prices 4.75M ADS IPO at $5.50/ADS
-
WiMi Hologram Cloud Inc. Announces Pricing of Initial Public Offering
-
Hoth Therapeutics Inc. (HOTH) Prices 1.449M Share Common Offering at $3.45/Sh
-
Hoth Announces Pricing of $5 Million Public Offering of Common Stock
-
Hoth Therapeutics Inc. (HOTH) Announces Proposed Public Offering of Common Stock
-
Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
-
The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc.
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics (SEEL) Prices 7.5M Share Common Offering at $0.60/Sh
-
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
-
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
-
Seelos Therapeutics (SEEL) Announces Proposed Public Offering of Common Stock
-
Seelos Therapeutics Announces Proposed Public Offering of Common Stock
-
Seelos Therapeutics Announces Proposed Public Offering of Common Stock
-
Cornerstone Building Brands to participate at The Benchmark Company's Construction & Industrials Inaugural Investor Conference on March 19, 2020
-
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
-
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
-
Fortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment Option
-
Fortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment Option
-
Duos Technologies Announces Exercise of Over-Allotment Option
-
Duos Technologies Announces Closing of Public Offering
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
-
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
-
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
-
Duos Technologies Group (DUOT) Prices 1.35M Share Common Offering at $6/Sh; Shares Approved for NASDAQ Listing
-
Duos Technologies Announces Pricing of Public Offering and NASDAQ Listing
-
The Benchmark Company Adds Kevin Sterling to Industrial Research Team
-
The Benchmark Company Adds Kevin Sterling to Industrial Research Team
-
Lakeland Industries Announces Upcoming Investor Events
-
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
-
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
-
Seelos Therapeutics (SEEL) Prices 6.667M Share Common Offering at $0.75/Sh
-
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
-
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
-
Updated Dial-In Information for Exchange Call with Contura Management
-
Contura Energy (CTRA) Announces Updated 2020 Guidance and Preliminary Q4 Results
-
Contura Announces Updated 2020 Guidance and Certain Preliminary, Unaudited Fourth Quarter 2019 Results
-
Nephros, Inc. (NEPH) Prices 937.5K Share Common Offering at $8/Sh
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
-
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock

